Trinity Biotech (TRIB) Accumulated Expenses (2010 - 2025)
Trinity Biotech (TRIB) posted Accumulated Expenses of $16.9 million for Q4 2025, up 24.53% sequentially from $13.6 million in Q4 2024, and up 24.53% YoY from $13.6 million in Q4 2024.
Trinity Biotech (TRIB) Accumulated Expenses (2010 - 2025) Analysis & Trends
Trinity Biotech has reported Accumulated Expenses for 8 years, with the latest figure at $16.9 million in Q4 2025.
- Quarterly Accumulated Expenses rose 24.53% year-over-year to $16.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.9 million (up 24.53% YoY) and the FY2025 annual result came in at $16.9 million, up 24.53% from the prior year.
- Accumulated Expenses grew to $16.9 million in Q4 2025 per TRIB's latest filing, from $13.6 million in the prior quarter.
- Over five years, Accumulated Expenses peaked at $16.9 million in Q4 2025 and troughed at $13.6 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.53 Mn | 1.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.93 Mn |
| Dec 31, 2024 | 13.60 Mn |
| Dec 31, 2020 | 8.85 Mn |
| Dec 31, 2019 | 8.13 Mn |
| Dec 31, 2018 | 7.88 Mn |
| Dec 31, 2017 | 11.62 Mn |
| Dec 31, 2016 | 10.88 Mn |
| Dec 31, 2010 | -301,000.00 |